Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FPQH9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,441
Award facts
- Contract value 100% obligated
- $16,441.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,441.36 by the Defense Logistics Agency on April 24, 2025. The delivery order is for Stelara 90 mg/ml syringes, a biologic medication used to treat autoimmune conditions, with an ultimate completion date of May 15, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace based on its established capabilities and pricing competitiveness.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 blanket purchase agreement valid through November 2026. The underlying IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities nationwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs, biologics, and medical consumables to military health facilities, with this particular order fulfilling the medical supply needs of the Defense Logistics Agency's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DB25FPQH9?
SPE2DB25FPQH9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FPQH9 worth?
The government has obligated $16,441 on SPE2DB25FPQH9.
Is contract SPE2DB25FPQH9 an order under another contract?
Yes. SPE2DB25FPQH9 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQH9 competed?
The extent of competition for SPE2DB25FPQH9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award